When the FDA approved Wegovy (semaglutide), it became the first medication of its kind that’s specifically for weight loss. Many other weight-loss medications are in the pipeline. This may create a wide range of options that work in slightly different ways for people to choose from.
In this video, find out which medications are currently FDA approved, and which ones may be approved in the future, according to Stacia Woodcock, PharmD, Pharmacy Editor at GoodRx.
Stacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.
References
American Society of Health-System Pharmacists. (2023). Semaglutide injection.
Collins, L., et al. (2022). Glucagon-like peptide-1 receptor agonists. StatPearls.
Eli Lilly and Company. (2023). ZEPBOUND (tirzepatide) injection, for subcutaneous use [package insert].
Novo Nordisk. (2022). Ozempic [package insert].
Novo Nordisk. (2022). Wegovy [package insert].
U.S. Food and Drug Administration. (2021). FDA approves new drug treatment for chronic weight management, first since 2014.
U.S. Food and Drug Administration. (2023). Medications containing semaglutide marketed for Type 2 diabetes or weight loss.
Why trust our experts?
